TC
HZNP

TownSquare Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

TownSquare Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,789
Closed -$207K – 1222
2023
Q3 		$207K Buy
+1,789
New +$192K ﹤0.01% 1029
2023
Q2 		– Sell
-18,273
Closed -$1.99M – 1130
2023
Q1 		$1.99M Sell
18,273
-30,822
-63% -$3.41M 0.04% 324
2022
Q4 		$5.59M Buy
49,095
+3,117
+7% +$259K 0.14% 140
2022
Q3 		$2.85M Buy
45,978
+4,320
+10% +$302K 0.08% 208
2022
Q2 		$3.32M Sell
41,658
-1,924
-4% -$182K 0.09% 190
2022
Q1 		$4.58M Buy
43,582
+1,680
+4% +$164K 0.12% 156
2021
Q4 		$4.52M Buy
41,902
+3,243
+8% +$354K 0.11% 158
2021
Q3 		$4.24M Buy
38,659
+9,379
+32% +$974K 0.12% 152
2021
Q2 		$2.81M Buy
29,280
+4,724
+19% +$435K 0.09% 196
2021
Q1 		$2.26M Buy
24,556
+6,114
+33% +$516K 0.09% 189
2020
Q4 		$1.35M Buy
18,442
+2,655
+17% +$197K 0.06% 243
2020
Q3 		$1.26M Buy
15,787
+2,341
+17% +$161K 0.07% 201
2020
Q2 		$751K Buy
+13,446
New +$575K 0.05% 231

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TownSquare Capital's HZNP Position: Q4 2023 in Review

TownSquare Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,789 shares — an estimated $207K sold.

TownSquare Capital first reported a position in HZNP in Q2 2020 and held it in 13 quarters. The position peaked at $5.59M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • TownSquare Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • TownSquare Capital sold 1,789 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $207K.
  • TownSquare Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 13 quarters.
  • TownSquare Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.59M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on TownSquare Capital's 13F filing for Q4 2023, filed 15 Feb 2024.